Stock NMTRQ 9 METERS BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

9 Meters Biopharma, Inc. Stock

Equities

NMTRQ

US6544052086

Investment Holding Companies

Delayed OTC Markets
Other stock markets
 11:41:27 2024-05-06 am EDT 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for 9 Meters Biopharma, Inc. 0.00% 0.00%
Mar. 25 North American Morning Briefing : Tech in Focus on -2- DJ
2023 Bidding Procedure Approved for 9 Meters Biopharma, Inc. CI
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials (USD)

Sales 2021 - Sales 2022 - Capitalization 16.32M
Net income 2021 -36M Net income 2022 -43M EV / Sales 2021 -
Net cash position 2021 46.83M Net Debt 2022 7.08M EV / Sales 2022 -
P/E ratio 2021
-6.47 x
P/E ratio 2022
-0.37 x
Employees 10
Yield 2021 *
-
Yield 2022
-
Free-Float 98.29%
More Fundamentals * Assessed data

Chart 9 Meters Biopharma, Inc.

Dynamic Chart

Latest news about 9 Meters Biopharma, Inc.

North American Morning Briefing : Tech in Focus on -2- DJ
Bidding Procedure Approved for 9 Meters Biopharma, Inc. CI
Amendment to Motion for Asset Sale Filed by 9 Meters Biopharma, Inc. CI
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc. CI
North American Morning Briefing : Stocks Look to -2- DJ
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc. CI
North American Morning Briefing : Stock Futures -2- DJ
North American Morning Briefing : Mood Seen Buoyed -2- DJ
North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh DJ
North American Morning Briefing : Jobs Report Eyed for Hiring Slowdown DJ
North American Morning Briefing : Investors Await Powell's Jackson Hole Speech DJ
North American Morning Briefing : China Trouble Hits Sentiment DJ
North American Morning Briefing : Stock Futures -2- DJ
Illumina cuts annual profit forecast as biotech funding woes linger RE
Illumina cuts annual profit forecast RE
More news

Analyst Recommendations on 9 Meters Biopharma, Inc.

North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh DJ
Citigroup Adjusts 9 Meters Biopharma Price Target to $0.75 From $1.70, Maintains Neutral Rating MT
Truist Downgrades 9 Meters Biopharma to Hold From Buy MT
Citigroup Initiates Coverage on 9 Meters Biopharma With Neutral Rating, $2.70 Price Target MT
Oppenheimer Adjusts 9 Meters Biopharma Price Target to $51 From $5, Maintains Outperform Rating MT
More recommendations

Press releases 9 Meters Biopharma, Inc.

Celiac Disease Pipeline, Clinical Trials, FDA Approvals, and Emerging Drugs 2023 (Updated) AQ
9 METERS BIOPHARMA, INC. : Change in Directors or Principal Officers (form 8-K) AQ
9 METERS BIOPHARMA, INC. : Other Events (form 8-K) AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Financial Statements and Exhibits (form 8-K) AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) AQ
More press releases

Highs and lows

Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.85
3 years
0.00
Extreme 0
31.00
5 years
0.00
Extreme 0
45.20
10 years
0.00
Extreme 0
1 010.00
More quotes

Quotes

Date Price Change Volume
24-05-06 0.000001 0.00% 1,208
24-05-02 0.000001 0.00% 105
24-05-01 0.000001 0.00% 2,825

Delayed Quote OTC Markets, May 06, 2024 at 11:41 am EDT

More quotes

Company Profile

9 Meters Biopharma, Inc. has ceased operations. The Company has filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the Bankruptcy Code) in the United States Bankruptcy Court for the Eastern District of North Carolina.
Sector
Investment Holding Companies
Calendar
2024-05-13 - Q1 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Quarterly earnings - Rate of surprise

Company calendar

Sector Shell Companies

1st Jan change Capi.
9 METERS BIOPHARMA, INC. Stock 9 Meters Biopharma, Inc.
0.00% 14
TRUMP MEDIA & TECHNOLOGY GROUP CORP. Stock Trump Media & Technology Group Corp.
+182.23% 6.52B
SCREAMING EAGLE ACQUISITION CORP. Stock Screaming Eagle Acquisition Corp.
+12.41% 1.07B
CHURCHILL CAPITAL CORP VII Stock Churchill Capital Corp VII
+2.14% 982M
APPLE ISPORTS GROUP, INC. Stock Apple iSports Group, Inc.
+41.91% 872M
PERELLA WEINBERG PARTNERS Stock Perella Weinberg Partners
+19.46% 777M
E7 GROUP Stock E7 Group
+11.31% 680M
ARES ACQUISITION CORPORATION II Stock Ares Acquisition Corporation II
+1.82% 664M
ALTC ACQUISITION CORP. Stock AltC Acquisition Corp.
+46.02% 618M
DA ZHONG TRADING GROUP HOLDING COMPANY Stock Da Zhong Trading Group Holding Company
-.--% 600M
Shell Companies
  1. Stock Market
  2. Equities
  3. NMTRQ Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW